News Chart Spyre Therapeutics, Inc.

Equities

SYRE

US00773J2024

Market Closed - Nasdaq Other stock markets 01:30:00 16/05/2024 am IST			5-day change	1st Jan Change
37.38 ^USD	-4.86%		+13.20%	+73.70%

13/05	Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating	MT
09/05	Spyre Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

87a34fe9e4f1fc50224.UrSo3cSHZgySMGTBd53v6t0gIu_9ZvFWxs2QAxoehsw.F9zKrabRCU2qAwKjGs-dprwZVraeUIYXtJrjMW5U4pwah_GLjbYWfNNFXA~cac35fc47da3c3d3056b0c8b8ce626ea